- Home
- SCYX vs MGLD Comparison
SCYX vs MGLD Comparison
Compare SCYX & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- MGLD
- Stock Information
- Founded
- SCYX 1999
- MGLD 1996
- Country
- SCYX United States
- MGLD United States
- Employees
- SCYX N/A
- MGLD N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- MGLD Finance/Investors Services
- Sector
- SCYX Health Care
- MGLD Finance
- Exchange
- SCYX Nasdaq
- MGLD Nasdaq
- Market Cap
- SCYX 50.3M
- MGLD 59.9M
- IPO Year
- SCYX 2014
- MGLD N/A
- Fundamental
- Price
- SCYX $0.99
- MGLD $1.65
- Analyst Decision
- SCYX Buy
- MGLD
- Analyst Count
- SCYX 1
- MGLD 0
- Target Price
- SCYX N/A
- MGLD N/A
- AVG Volume (30 Days)
- SCYX 212.6K
- MGLD 13.9K
- Earning Date
- SCYX 11-06-2024
- MGLD 02-12-2025
- Dividend Yield
- SCYX N/A
- MGLD N/A
- EPS Growth
- SCYX N/A
- MGLD N/A
- EPS
- SCYX N/A
- MGLD N/A
- Revenue
- SCYX $8,566,000.00
- MGLD $32,511,000.00
- Revenue This Year
- SCYX N/A
- MGLD N/A
- Revenue Next Year
- SCYX $405.82
- MGLD N/A
- P/E Ratio
- SCYX N/A
- MGLD N/A
- Revenue Growth
- SCYX N/A
- MGLD N/A
- 52 Week Low
- SCYX $0.90
- MGLD $0.78
- 52 Week High
- SCYX $3.07
- MGLD $2.10
- Technical
- Relative Strength Index (RSI)
- SCYX 30.44
- MGLD 54.95
- Support Level
- SCYX $0.90
- MGLD $1.32
- Resistance Level
- SCYX $1.25
- MGLD $2.10
- Average True Range (ATR)
- SCYX 0.08
- MGLD 0.20
- MACD
- SCYX -0.01
- MGLD 0.03
- Stochastic Oscillator
- SCYX 23.54
- MGLD 48.28
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About MGLD The Marygold Companies Inc.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.